MAPT and Parkinson disease: Furthermore, there is a genetic interaction between MAPT and the α-synuclein gene (SNCA) in which the high-expression MAPT haplotype (H1) and a polymorphism in SNCA synergistically increase PD risk (Goris et al., 2007).